ロード中...
Anabolic Therapies
The striking clinical benefits of intermittent parathyroid hormone in osteoporosis have begun a new era of skeletal anabolic agents. Recombinant human parathyroid hormone (rhPTH) (1–34) is the first US Food and Drug Administration–approved anabolic therapy. Its use has been limited by the need for s...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Current Science Inc.
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2841260/ https://ncbi.nlm.nih.gov/pubmed/20425087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11914-010-0005-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|